Total Funding
3
7
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-50 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
464084
Elute is a developer of polymer-controlled drug delivery devices design to prevent and treat orthopedic and other surgical bone infections.
Ashok C Khandkar: Chief Executive OfficerPast Role: Bloxr, Founder, CTO- Dennis Farrar: Executive Chairman and co-founder
About the Company
Elute develops polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections. ElutiBone, its lead product candidate, claims to significantly improve patient outcomes and transform the management of peri-prosthetic bone infections. It is supposed to have delivered an initial burst of tobramycin
directly to the infected site at a concentration high enough to treat the infection without compromising bone growth.
